Try our Advanced Search for more refined results

USA v. Facteau et al

  1. August 22, 2016

    Judge Explains Rulings In Acclarent Criminal Cases

    A Massachusetts federal judge released a memorandum Monday explaining her previous oral rulings in a criminal case against two medical device executives that ended in misdemeanor misbranding and adulteration convictions, offering a record of her reasoning as the executives prepare their appeals.

  2. August 18, 2016

    Ex-Acclarent Execs Want Travel Restrictions Lifted

    Two medical device executives who were convicted of misdemeanor violations of federal misbranding and adulteration law are asking to have travel restrictions and bond conditions eased as they pursue their appeals.

  3. August 02, 2016

    Ex-Acclarent Execs Want Misdemeanor Convictions Tossed

    Two former executives of medical device manufacturer Acclarent Inc. asked a federal judge in Boston on Monday to throw out their misdemeanor misbranding and adulteration convictions.

  4. July 22, 2016

    Minor Convictions In Acclarent Trial Raise Major Questions

    A Massachusetts federal jury may have rejected a slew of felony fraud charges against a pair of former executives for medical-device manufacturer Acclarent this week, but its verdict convicting them of 10 misdemeanors may eventually force courts to venture into hazy territory to decide where free-speech rights end and illicit off-label promotion begins.

  5. July 20, 2016

    Ex-Acclarent Execs Beat Felony Off-Label Fraud Charges

    A Massachusetts federal jury acquitted two top former Acclarent executives Wednesday of a slew of felony fraud charges related to the company's promotion of a medical device off-label, but convicted the pair of 10 misdemeanor counts of introducing a misbranded and adulterated device into interstate commerce.

  6. July 15, 2016

    Ex-Acclarent Exec Takes Aim At FDA In Closing

    The attorney for a former medical device executive accused of a massive fraud on the health care industry told a Boston federal jury Friday that the charges against his client did not hold up to basic scrutiny, lacing a three-hour closing argument with criticisms of prosecutors and Food and Drug Administration regulators.

  7. July 14, 2016

    Jury Hears Rival Portraits Of Acclarent Execs In Fraud Trial

    Prosecutors told a Boston federal jury in closing arguments Thursday that two ex-Acclarent executives were the perpetrators of a massive fraud on the health care industry, while the defendants' attorneys said they were hardworking businessmen acting in good faith.

  8. July 13, 2016

    Life Sciences Cases To Watch In The 2nd Half Of 2016

    The second half of 2016 will produce industry-shaping court decisions regarding off-label marketing of medical devices, sales of biosimilars, drug exclusivity and anti-smoking regulations. Here are key cases to watch.

  9. July 08, 2016

    Acclarent Execs Ask Judge To Halt 'Confusing' Prosecution

    Lawyers for two former Acclarent Inc. medical device executives on Thursday urged the Boston federal judge overseeing their fraud trial to toss all remaining counts against them, arguing that the federal government has presented a case that no reasonable jury could convict them on.

  10. June 28, 2016

    Acclarent Didn't Tell FDA About Adverse Events, Jury Told

    Medical device maker Acclarent Inc. never told regulators that half the patients in a 2007 study for a sinus clearing device developed infections, even though that information should have been turned over, a federal jury in Boston was told Tuesday.